| Authors: |
Suraj-Prażmowska J; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland. joanna.suraj@jcet.eu., Sternak M; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Kurpińska A; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Bar A; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Czyżyńska-Cichoń I; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Ascencao K; University of Fribourg, Faculty of Science and Medicine, Department of Oncology, Microbiology and Immunology, Section of Pharmacology, Fribourg, Switzerland., Niedzielska-Andres E; Jagiellonian University, Jagiellonian University Medical College, Faculty of Pharmacy, Chair and Department of Toxicology, Krakow, Poland., Buczek E; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Mateuszuk Ł; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Karaś A; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland., Walczak M; Jagiellonian University, Jagiellonian University Medical College, Faculty of Pharmacy, Chair and Department of Toxicology, Krakow, Poland., Szabo C; University of Fribourg, Faculty of Science and Medicine, Department of Oncology, Microbiology and Immunology, Section of Pharmacology, Fribourg, Switzerland., Chlopicki S; Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland. stefan.chlopicki@jcet.eu.; Jagiellonian University Medical College, Department of Pharmacology, Krakow, Poland. stefan.chlopicki@jcet.eu. |